TR199902730T2 - Glikrizikasit ve antiviral etkinlik kazandirilmis en azindan bir proteini içeren farmasötik antiviral bilesim. - Google Patents

Glikrizikasit ve antiviral etkinlik kazandirilmis en azindan bir proteini içeren farmasötik antiviral bilesim.

Info

Publication number
TR199902730T2
TR199902730T2 TR1999/02730T TR9902730T TR199902730T2 TR 199902730 T2 TR199902730 T2 TR 199902730T2 TR 1999/02730 T TR1999/02730 T TR 1999/02730T TR 9902730 T TR9902730 T TR 9902730T TR 199902730 T2 TR199902730 T2 TR 199902730T2
Authority
TR
Turkey
Prior art keywords
antiviral
composition containing
pharmaceutical
glycyrrhizic acid
containing glycyrrhizic
Prior art date
Application number
TR1999/02730T
Other languages
English (en)
Inventor
Pompei Raffaello
Pinzo Mario
Original Assignee
Aziende Chimiche Riunite Angelini
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aziende Chimiche Riunite Angelini filed Critical Aziende Chimiche Riunite Angelini
Publication of TR199902730T2 publication Critical patent/TR199902730T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

Glikrizik asit ve antiviral etkinlik kazandirilmis en azindan bir proteini içeren farmasötik bilesim.
TR1999/02730T 1997-05-14 1998-05-06 Glikrizikasit ve antiviral etkinlik kazandirilmis en azindan bir proteini içeren farmasötik antiviral bilesim. TR199902730T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT97MI001119A IT1291366B1 (it) 1997-05-14 1997-05-14 Composizione farmaceutica antivirale comprendente acido glicirrizico ed almeno una proteina dotata di attivita' antivirale

Publications (1)

Publication Number Publication Date
TR199902730T2 true TR199902730T2 (tr) 2000-02-21

Family

ID=11377123

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1999/02730T TR199902730T2 (tr) 1997-05-14 1998-05-06 Glikrizikasit ve antiviral etkinlik kazandirilmis en azindan bir proteini içeren farmasötik antiviral bilesim.

Country Status (27)

Country Link
US (1) US6329339B1 (tr)
EP (1) EP0980254B1 (tr)
JP (2) JP2001525814A (tr)
KR (1) KR100592193B1 (tr)
CN (1) CN1114447C (tr)
AR (1) AR012849A1 (tr)
AT (1) ATE212232T1 (tr)
AU (1) AU740944B2 (tr)
BG (1) BG64748B1 (tr)
CA (1) CA2289550A1 (tr)
CZ (1) CZ291932B6 (tr)
DE (1) DE69803565T2 (tr)
DK (1) DK0980254T3 (tr)
EA (1) EA003126B1 (tr)
ES (1) ES2170501T3 (tr)
GE (1) GEP20022672B (tr)
HK (1) HK1028347A1 (tr)
HU (1) HU224956B1 (tr)
IL (2) IL132651A0 (tr)
IT (1) IT1291366B1 (tr)
PL (1) PL189218B1 (tr)
PT (1) PT980254E (tr)
SK (1) SK283584B6 (tr)
TR (1) TR199902730T2 (tr)
UA (1) UA63955C2 (tr)
WO (1) WO1998051334A1 (tr)
ZA (1) ZA983917B (tr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7151082B2 (en) * 1999-02-11 2006-12-19 The Feinstein Institute For Medical Research Antagonists of HMG1 for treating inflammatory conditions
US6303321B1 (en) * 1999-02-11 2001-10-16 North Shore-Long Island Jewish Research Institute Methods for diagnosing sepsis
US7304034B2 (en) 2001-05-15 2007-12-04 The Feinstein Institute For Medical Research Use of HMGB fragments as anti-inflammatory agents
AU2003225073A1 (en) * 2002-04-18 2003-11-03 The University Of Iowa Research Foundation Methods of inhibiting and treating bacterial biofilms by metal chelators
US7696169B2 (en) * 2003-06-06 2010-04-13 The Feinstein Institute For Medical Research Inhibitors of the interaction between HMGB polypeptides and toll-like receptor 2 as anti-inflammatory agents
EP1668035A2 (en) * 2003-09-11 2006-06-14 Critical Therapeutics, Inc. Monoclonal antibodies against hmgb1
US20100040608A1 (en) * 2005-07-18 2010-02-18 Marie Wahren-Herlenius Use of HMGB1 antagonists for the treatment of inflammatory skin conditions
CA2631212A1 (en) * 2005-11-28 2007-07-05 Medimmune, Llc Antagonists of hmgb1 and/or rage and methods of use thereof
IT1391170B1 (it) * 2008-08-07 2011-11-18 D M G Italia S R L Composizione topica intra-nasale utilizzabile in caso di ostruzione nasale
WO2012026928A1 (en) * 2010-08-25 2012-03-01 Diacarta Llc Use of glycyrrhetinic acid, glycyrrhizic acid and related compounds for prevention and/or treatment of pulmonary fibrosis
US9416151B2 (en) 2010-08-25 2016-08-16 Lurong ZHANG Use of glycyrrhetinic acid, glycyrrhizic acid and related compounds for prevention and/or treatment of pulmonary fibrosis
JP5806434B1 (ja) * 2014-02-21 2015-11-10 国立大学法人東京海洋大学 ノロウィルス不活化剤及びその製造方法、ノロウィルス不活化方法、ノロウィルス不活化用リゾチーム類の製造方法、ノロウィルス感染の予防薬又は治療薬、並びにノロウィルス不活化用皮膚外用剤
AU2017224113B2 (en) * 2016-02-25 2022-04-21 Applied Biological Laboratories, Inc. Compositions and methods for protecting against airborne pathogens and irritants
CN109022351B (zh) * 2018-09-28 2021-10-19 广州奇龙生物科技有限公司 重组人溶菌酶的新应用
CN112135625B (zh) * 2020-04-27 2021-07-06 广州新创忆药物临床研究有限公司 一种预防或治疗covid-19新冠肺炎的药物及其应用
CN113304253A (zh) * 2020-04-27 2021-08-27 湘北威尔曼制药股份有限公司 一种辅助预防或辅助治疗新冠肺炎的食物及其应用
CN117898418A (zh) * 2020-04-27 2024-04-19 湘北威尔曼制药股份有限公司 一种对新冠病毒损伤有辅助保护作用的食物及其应用
MX2021005280A (es) * 2021-05-04 2022-02-23 Spv Timser S A P I De C V Composicion farmaceutica que contiene triterpenoides pentaciclicos.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH085800B2 (ja) * 1986-12-19 1996-01-24 エーザイ株式会社 塩化リゾチ−ム及びグリチルリチン酸ジカリウム含有水溶液製剤
JP2838720B2 (ja) * 1989-10-31 1998-12-16 ゼリア新薬工業株式会社 安定な点眼剤
JP4056099B2 (ja) * 1996-05-09 2008-03-05 森永乳業株式会社 水生動物の寄生生物性疾患の予防および治療剤

Also Published As

Publication number Publication date
AU7764698A (en) 1998-12-08
WO1998051334A1 (en) 1998-11-19
DE69803565D1 (de) 2002-03-14
ATE212232T1 (de) 2002-02-15
JP2001525814A (ja) 2001-12-11
UA63955C2 (uk) 2004-02-16
PL189218B1 (pl) 2005-07-29
DE69803565T2 (de) 2002-08-08
ITMI971119A1 (it) 1998-11-14
AR012849A1 (es) 2000-11-22
CN1114447C (zh) 2003-07-16
ZA983917B (en) 1998-11-09
PT980254E (pt) 2002-07-31
IL132651A0 (en) 2001-03-19
KR100592193B1 (ko) 2006-06-23
KR20010012419A (ko) 2001-02-15
CA2289550A1 (en) 1998-11-19
CN1255859A (zh) 2000-06-07
PL336802A1 (en) 2000-07-17
ES2170501T3 (es) 2002-08-01
EP0980254A1 (en) 2000-02-23
HK1028347A1 (en) 2001-02-16
JP2009102370A (ja) 2009-05-14
GEP20022672B (en) 2002-04-25
IT1291366B1 (it) 1999-01-07
BG64748B1 (bg) 2006-02-28
ITMI971119A0 (tr) 1997-05-14
HU224956B1 (en) 2006-04-28
EP0980254B1 (en) 2002-01-23
HUP0002985A3 (en) 2001-04-28
CZ399199A3 (cs) 2000-04-12
CZ291932B6 (cs) 2003-06-18
US6329339B1 (en) 2001-12-11
IL132651A (en) 2006-10-31
EA199901024A1 (ru) 2000-06-26
BG103968A (en) 2000-07-31
EA003126B1 (ru) 2003-02-27
SK154499A3 (en) 2000-08-14
SK283584B6 (sk) 2003-10-07
HUP0002985A2 (hu) 2001-01-29
AU740944B2 (en) 2001-11-15
DK0980254T3 (da) 2002-05-06

Similar Documents

Publication Publication Date Title
TR199902730T2 (tr) Glikrizikasit ve antiviral etkinlik kazandirilmis en azindan bir proteini içeren farmasötik antiviral bilesim.
ATE282600T1 (de) Salpetersäuresalze von antihypertensiven arzneimitteln
TR199800046A2 (tr) Aktif maddeler yaratilmasi için nükleik asit olusumu.
DE3863672D1 (de) Aktives magnetlager mit stuetzlager.
IT1232827B (it) Proteine biologicamente attive, formulazioni che le contengono e metodo per prepararle ed applicarle
DE3586948D1 (de) Polyamidsaeure-loesung und daraus hergestellter film.
DK155318C (da) Indoxyl- og thioindoxyl-aminosyreestere og -peptidestere, diagnostisk middel indeholdende dem, og deres anvendelse i diagnostiske midler
ID30181A (id) Asam antranilat- dan asam tioantranilat-n-aril amida
DE3853526D1 (de) Active Dünnschicht-Matrix und zugehörige Adressierungsschaltung.
KR870700004A (ko) 하나이상의 활성성분을 가지는 살충제 조성물
DE69833333D1 (de) Pharmazeutische zusammensetzung enthaltend geweihextrakte von cervus nippon mit wachstumsstimulierender aktivität auf hematopoietische stammzellen und megakaryozyten
IT8319490A0 (it) S-adenosil metionina in cellule microbiche contenenti concentrazione elevata eprocedimento per la produzione di s-adenosil metionina.
DE68914571D1 (de) Elektroeinsetzung von Proteinen in Membranen von Tierzellen.
IT1270618B (it) Proteine ad attivita' antitumorale
ATE226087T1 (de) Verwendung von neuen zelltod inducierenden mitteln im synergismus mit interferon
DE3887456D1 (de) Elektrochemische Zelle.
DK109590A (da) Biologisk aktivt protein
OA08349A (fr) Acides propenylaminothiazolylcephalosporaniques 3-substitués et leurs esters.
DE3667325D1 (de) Ziel.
DE3673436D1 (de) Gene fuer biologisch aktive proteine.
FI880636A0 (fi) Foerfarande foer inaktivering av med hoelje foersedda virus i en medelst en cell in vitro framstaellda proteinprodukter.
IT8420082A0 (it) Agenti ad attivita'antibroncospastica e composizioni farmaceutiche che li contengono.
DE69005312T2 (de) Stromart abtast-und-halteverstärker.
DE3152363T1 (tr)
FR2716661B1 (fr) Chariots de stockage et notamment échelles pâtissières et de laboratoire.